Anticoagulant Treatment of COVID-19 as Early as Possible-Sulodexide and Perspectives
- PMID: 33831961
- DOI: 10.1055/a-1477-3569
Anticoagulant Treatment of COVID-19 as Early as Possible-Sulodexide and Perspectives
Conflict of interest statement
None declared.
Comment on
-
Sulodexide in the Treatment of Patients with Early Stages of COVID-19: A Randomized Controlled Trial.Thromb Haemost. 2021 Jul;121(7):944-954. doi: 10.1055/a-1414-5216. Epub 2021 May 9. Thromb Haemost. 2021. PMID: 33677827 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical